New energy device could make ovary removal surgery safer and faster
NCT ID NCT07379411
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares a new energy-based surgical device (LigaSure Maryland) to the standard 'knot-and-cut' method for removing fallopian tubes and ovaries during vaginal hysterectomy for pelvic organ prolapse. Researchers will measure procedure time, blood loss, pain, and recovery in 70 women randomly assigned to one of the two techniques. The goal is to see if the energy-based approach is safer or more effective.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
LigaSure Maryland device
What this could lead to
If successful, this could make ovary removal during vaginal hysterectomy faster, with less blood loss and pain, leading to quicker recovery.
What could go wrong
This is a small, early-stage study (70 participants) comparing surgical techniques, so results may not apply broadly. The device may not prove safer or more effective than the standard approach.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PELVIC ORGAN PROLAPSE (POP) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Wolfson Medical Center
RECRUITINGHolon, Israel
Contact Phone: •••-•••-•••• Email: •••••@•••••